Production (Stage)
BioSig Technologies, Inc.
BSGM
$5.23
-$0.63-10.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.74M | -10.33M | -15.28M | -17.93M | -25.11M |
| Total Depreciation and Amortization | 411.00K | 504.00K | 603.00K | 616.00K | 654.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.69M | 4.71M | 11.70M | 9.32M | 9.51M |
| Change in Net Operating Assets | -919.00K | 363.00K | -4.25M | -1.57M | 1.97M |
| Cash from Operations | -4.56M | -4.76M | -7.23M | -9.57M | -12.98M |
| Capital Expenditure | -- | -- | -4.00K | -64.00K | -141.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -4.00K | -64.00K | -141.00K |
| Total Debt Issued | 0.00 | 500.00K | 500.00K | 500.00K | 500.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.87M | 4.21M | 6.95M | 9.58M | 9.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 3.00K | 404.00K | 1.97M |
| Cash from Financing | 7.87M | 4.71M | 7.46M | 10.48M | 12.12M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.31M | -48.00K | 226.00K | 852.00K | -996.00K |